Sarcopenia and health-related outcomes: an umbrella review of observational studies

the Special Interest Groups in Systematic Reviews and Meta-analyses for healthy ageing Sarcopenia and Frailty and resilience in older persons of the European Geriatric Medicine Society (EuGMS), Nicola Veronese, Jacopo Demurtas, Pinar Soysal, Lee Smith, Gabriel Torbahn, Daniel Schoene, Lukas Schwingshackl, Cornel Sieber, Jurgen Bauer, Matteo Cesari, Oliviere Bruyere, Jean Yves Reginster, Charlotte Beaudart, Alfonso J. Cruz-Jentoft, Cyrus Cooper, Mirko Petrovic, Stefania Maggi

Research output: Contribution to journalReview article

Abstract

Background: The clinical relevance of sarcopenia has increasingly been recognized. However, whether it is associated with the development of other medical conditions is still unclear. Therefore, we aimed to capture the scale of outcomes that have been associated with the presence of sarcopenia and systematically assess the quality, strength, and credibility of these associations using an umbrella review methodology. Methods: A systematic review in several databases was carried out, until 20th February 2019. For each association, random-effects summary effect size, 95% confidence intervals (CIs), heterogeneity (I 2), evidence for small-study effect, evidence for excess significance bias, and 95%-prediction intervals were estimated. We used these metrics to categorize the evidence of significant outcomes (p < 0.05) from class I (convincing) to class IV (weak), according to pre-established criteria. Results: From 358 abstracts, 6 meta-analyses with 14 associations were included. Sarcopenia was associated with higher risk of other comorbidities and mortality in 11 of 14 outcomes explored. However, only 3 outcomes (i.e., association between sarcopenia and increased risk of death in community-dwelling older people [odds ratio, OR = 3.60; 95% CI 2.96–4.37; n = 14,305], disability [OR = 3.04; 95% CI 1.80–5.12; n = 8569], and falls [OR = 1.60; 95% CI 1.31–1.97; n = 12,261]) presented a highly suggestive evidence (class II). Other association was classified as having only a weak evidence. Conclusion: Sarcopenia is associated with several adverse health-related outcomes in older people, and its associations with mortality, disability, and falls are supported by a highly suggestive evidence. The effect of interventions on sarcopenia to improve these outcomes needs to be investigated.

Original languageEnglish
Pages (from-to)853–862
JournalEuropean Geriatric Medicine
Volume10
Issue number6
DOIs
Publication statusPublished - 2019

Fingerprint

Sarcopenia
Observational Studies
Health
Confidence Intervals
Independent Living
Mortality
Meta-Analysis
Comorbidity
Odds Ratio
Databases

Keywords

  • Disability
  • Fall
  • Health
  • Meta-analysis
  • Mortality
  • Risk factor
  • Sarcopenia
  • Umbrella review

ASJC Scopus subject areas

  • Gerontology
  • Geriatrics and Gerontology

Cite this

the Special Interest Groups in Systematic Reviews and Meta-analyses for healthy ageing Sarcopenia and Frailty and resilience in older persons of the European Geriatric Medicine Society (EuGMS), Veronese, N., Demurtas, J., Soysal, P., Smith, L., Torbahn, G., ... Maggi, S. (2019). Sarcopenia and health-related outcomes: an umbrella review of observational studies. European Geriatric Medicine, 10(6), 853–862. https://doi.org/10.1007/s41999-019-00233-w

Sarcopenia and health-related outcomes : an umbrella review of observational studies. / the Special Interest Groups in Systematic Reviews and Meta-analyses for healthy ageing Sarcopenia and Frailty and resilience in older persons of the European Geriatric Medicine Society (EuGMS); Veronese, Nicola; Demurtas, Jacopo; Soysal, Pinar; Smith, Lee; Torbahn, Gabriel; Schoene, Daniel; Schwingshackl, Lukas; Sieber, Cornel; Bauer, Jurgen; Cesari, Matteo; Bruyere, Oliviere; Reginster, Jean Yves; Beaudart, Charlotte; Cruz-Jentoft, Alfonso J.; Cooper, Cyrus; Petrovic, Mirko; Maggi, Stefania.

In: European Geriatric Medicine, Vol. 10, No. 6, 2019, p. 853–862.

Research output: Contribution to journalReview article

the Special Interest Groups in Systematic Reviews and Meta-analyses for healthy ageing Sarcopenia and Frailty and resilience in older persons of the European Geriatric Medicine Society (EuGMS), Veronese, N, Demurtas, J, Soysal, P, Smith, L, Torbahn, G, Schoene, D, Schwingshackl, L, Sieber, C, Bauer, J, Cesari, M, Bruyere, O, Reginster, JY, Beaudart, C, Cruz-Jentoft, AJ, Cooper, C, Petrovic, M & Maggi, S 2019, 'Sarcopenia and health-related outcomes: an umbrella review of observational studies', European Geriatric Medicine, vol. 10, no. 6, pp. 853–862. https://doi.org/10.1007/s41999-019-00233-w
the Special Interest Groups in Systematic Reviews and Meta-analyses for healthy ageing Sarcopenia and Frailty and resilience in older persons of the European Geriatric Medicine Society (EuGMS), Veronese N, Demurtas J, Soysal P, Smith L, Torbahn G et al. Sarcopenia and health-related outcomes: an umbrella review of observational studies. European Geriatric Medicine. 2019;10(6):853–862. https://doi.org/10.1007/s41999-019-00233-w
the Special Interest Groups in Systematic Reviews and Meta-analyses for healthy ageing Sarcopenia and Frailty and resilience in older persons of the European Geriatric Medicine Society (EuGMS) ; Veronese, Nicola ; Demurtas, Jacopo ; Soysal, Pinar ; Smith, Lee ; Torbahn, Gabriel ; Schoene, Daniel ; Schwingshackl, Lukas ; Sieber, Cornel ; Bauer, Jurgen ; Cesari, Matteo ; Bruyere, Oliviere ; Reginster, Jean Yves ; Beaudart, Charlotte ; Cruz-Jentoft, Alfonso J. ; Cooper, Cyrus ; Petrovic, Mirko ; Maggi, Stefania. / Sarcopenia and health-related outcomes : an umbrella review of observational studies. In: European Geriatric Medicine. 2019 ; Vol. 10, No. 6. pp. 853–862.
@article{72599ad688ac425a94a202cd74e98a3d,
title = "Sarcopenia and health-related outcomes: an umbrella review of observational studies",
abstract = "Background: The clinical relevance of sarcopenia has increasingly been recognized. However, whether it is associated with the development of other medical conditions is still unclear. Therefore, we aimed to capture the scale of outcomes that have been associated with the presence of sarcopenia and systematically assess the quality, strength, and credibility of these associations using an umbrella review methodology. Methods: A systematic review in several databases was carried out, until 20th February 2019. For each association, random-effects summary effect size, 95{\%} confidence intervals (CIs), heterogeneity (I 2), evidence for small-study effect, evidence for excess significance bias, and 95{\%}-prediction intervals were estimated. We used these metrics to categorize the evidence of significant outcomes (p < 0.05) from class I (convincing) to class IV (weak), according to pre-established criteria. Results: From 358 abstracts, 6 meta-analyses with 14 associations were included. Sarcopenia was associated with higher risk of other comorbidities and mortality in 11 of 14 outcomes explored. However, only 3 outcomes (i.e., association between sarcopenia and increased risk of death in community-dwelling older people [odds ratio, OR = 3.60; 95{\%} CI 2.96–4.37; n = 14,305], disability [OR = 3.04; 95{\%} CI 1.80–5.12; n = 8569], and falls [OR = 1.60; 95{\%} CI 1.31–1.97; n = 12,261]) presented a highly suggestive evidence (class II). Other association was classified as having only a weak evidence. Conclusion: Sarcopenia is associated with several adverse health-related outcomes in older people, and its associations with mortality, disability, and falls are supported by a highly suggestive evidence. The effect of interventions on sarcopenia to improve these outcomes needs to be investigated.",
keywords = "Disability, Fall, Health, Meta-analysis, Mortality, Risk factor, Sarcopenia, Umbrella review",
author = "{the Special Interest Groups in Systematic Reviews and Meta-analyses for healthy ageing Sarcopenia and Frailty and resilience in older persons of the European Geriatric Medicine Society (EuGMS)} and Nicola Veronese and Jacopo Demurtas and Pinar Soysal and Lee Smith and Gabriel Torbahn and Daniel Schoene and Lukas Schwingshackl and Cornel Sieber and Jurgen Bauer and Matteo Cesari and Oliviere Bruyere and Reginster, {Jean Yves} and Charlotte Beaudart and Cruz-Jentoft, {Alfonso J.} and Cyrus Cooper and Mirko Petrovic and Stefania Maggi",
year = "2019",
doi = "10.1007/s41999-019-00233-w",
language = "English",
volume = "10",
pages = "853–862",
journal = "European Geriatric Medicine",
issn = "1878-7649",
publisher = "Elsevier Masson",
number = "6",

}

TY - JOUR

T1 - Sarcopenia and health-related outcomes

T2 - an umbrella review of observational studies

AU - the Special Interest Groups in Systematic Reviews and Meta-analyses for healthy ageing Sarcopenia and Frailty and resilience in older persons of the European Geriatric Medicine Society (EuGMS)

AU - Veronese, Nicola

AU - Demurtas, Jacopo

AU - Soysal, Pinar

AU - Smith, Lee

AU - Torbahn, Gabriel

AU - Schoene, Daniel

AU - Schwingshackl, Lukas

AU - Sieber, Cornel

AU - Bauer, Jurgen

AU - Cesari, Matteo

AU - Bruyere, Oliviere

AU - Reginster, Jean Yves

AU - Beaudart, Charlotte

AU - Cruz-Jentoft, Alfonso J.

AU - Cooper, Cyrus

AU - Petrovic, Mirko

AU - Maggi, Stefania

PY - 2019

Y1 - 2019

N2 - Background: The clinical relevance of sarcopenia has increasingly been recognized. However, whether it is associated with the development of other medical conditions is still unclear. Therefore, we aimed to capture the scale of outcomes that have been associated with the presence of sarcopenia and systematically assess the quality, strength, and credibility of these associations using an umbrella review methodology. Methods: A systematic review in several databases was carried out, until 20th February 2019. For each association, random-effects summary effect size, 95% confidence intervals (CIs), heterogeneity (I 2), evidence for small-study effect, evidence for excess significance bias, and 95%-prediction intervals were estimated. We used these metrics to categorize the evidence of significant outcomes (p < 0.05) from class I (convincing) to class IV (weak), according to pre-established criteria. Results: From 358 abstracts, 6 meta-analyses with 14 associations were included. Sarcopenia was associated with higher risk of other comorbidities and mortality in 11 of 14 outcomes explored. However, only 3 outcomes (i.e., association between sarcopenia and increased risk of death in community-dwelling older people [odds ratio, OR = 3.60; 95% CI 2.96–4.37; n = 14,305], disability [OR = 3.04; 95% CI 1.80–5.12; n = 8569], and falls [OR = 1.60; 95% CI 1.31–1.97; n = 12,261]) presented a highly suggestive evidence (class II). Other association was classified as having only a weak evidence. Conclusion: Sarcopenia is associated with several adverse health-related outcomes in older people, and its associations with mortality, disability, and falls are supported by a highly suggestive evidence. The effect of interventions on sarcopenia to improve these outcomes needs to be investigated.

AB - Background: The clinical relevance of sarcopenia has increasingly been recognized. However, whether it is associated with the development of other medical conditions is still unclear. Therefore, we aimed to capture the scale of outcomes that have been associated with the presence of sarcopenia and systematically assess the quality, strength, and credibility of these associations using an umbrella review methodology. Methods: A systematic review in several databases was carried out, until 20th February 2019. For each association, random-effects summary effect size, 95% confidence intervals (CIs), heterogeneity (I 2), evidence for small-study effect, evidence for excess significance bias, and 95%-prediction intervals were estimated. We used these metrics to categorize the evidence of significant outcomes (p < 0.05) from class I (convincing) to class IV (weak), according to pre-established criteria. Results: From 358 abstracts, 6 meta-analyses with 14 associations were included. Sarcopenia was associated with higher risk of other comorbidities and mortality in 11 of 14 outcomes explored. However, only 3 outcomes (i.e., association between sarcopenia and increased risk of death in community-dwelling older people [odds ratio, OR = 3.60; 95% CI 2.96–4.37; n = 14,305], disability [OR = 3.04; 95% CI 1.80–5.12; n = 8569], and falls [OR = 1.60; 95% CI 1.31–1.97; n = 12,261]) presented a highly suggestive evidence (class II). Other association was classified as having only a weak evidence. Conclusion: Sarcopenia is associated with several adverse health-related outcomes in older people, and its associations with mortality, disability, and falls are supported by a highly suggestive evidence. The effect of interventions on sarcopenia to improve these outcomes needs to be investigated.

KW - Disability

KW - Fall

KW - Health

KW - Meta-analysis

KW - Mortality

KW - Risk factor

KW - Sarcopenia

KW - Umbrella review

UR - http://www.scopus.com/inward/record.url?scp=85072035549&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072035549&partnerID=8YFLogxK

U2 - 10.1007/s41999-019-00233-w

DO - 10.1007/s41999-019-00233-w

M3 - Review article

AN - SCOPUS:85072035549

VL - 10

SP - 853

EP - 862

JO - European Geriatric Medicine

JF - European Geriatric Medicine

SN - 1878-7649

IS - 6

ER -